Antigone Kotsaki

4.4k total citations
27 papers, 637 citations indexed

About

Antigone Kotsaki is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Antigone Kotsaki has authored 27 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Antigone Kotsaki's work include Sepsis Diagnosis and Treatment (10 papers), Immune Response and Inflammation (6 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Antigone Kotsaki is often cited by papers focused on Sepsis Diagnosis and Treatment (10 papers), Immune Response and Inflammation (6 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Antigone Kotsaki collaborates with scholars based in Greece, Germany and United States. Antigone Kotsaki's co-authors include Evangelos J. Giamarellos‐Bourboulis, Georgia Damoraki, Mihai G. Netea, Nikolaos Antonakos, Antonios Papadopoulos, Maria‐Evangelia Adami, Hans J. P. M. Koenen, Simone J.C.F.M. Moorlag, Georgios Renieris and Theologia Gkavogianni and has published in prestigious journals such as Cell, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Antigone Kotsaki

27 papers receiving 627 citations

Peers

Countries citing papers authored by Antigone Kotsaki

Since Specialization

Citations

This map shows the geographic impact of Antigone Kotsaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antigone Kotsaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antigone Kotsaki more than expected).

Fields of papers citing papers by Antigone Kotsaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antigone Kotsaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antigone Kotsaki. The network helps show where Antigone Kotsaki may publish in the future.

Co-authorship network of co-authors of Antigone Kotsaki

This figure shows the co-authorship network connecting the top 25 collaborators of Antigone Kotsaki. A scholar is included among the top collaborators of Antigone Kotsaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antigone Kotsaki. Antigone Kotsaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA 2024 ·Journal of Antimicrobial Chemotherapy ·Sònia Luque, William Hope, Antigone Kotsaki, Shampa Das, Evangelos J. Giamarellos‐Bourboulis, (unknown), Karolina Akinosoglou, (unknown), Marie Attwood, Karen E. Bowker, Alan Noel, Andrew Lovering, Mark Bayliss, Rebecca Evans, Alasdair MacGowan	2
2	qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial 2024 ·Critical Care ·(unknown), Antigone Kotsaki, Nikolaos Antonakos, Efthymia Giannitsioti, Stamatios Chalvatzis, Maria Saridaki, Christina Avgoustou, Karolina Akinosoglou, (unknown), Georgia Damoraki, Konstantina Katrini, Panagiotis Koufargyris, Vasileios Lekakis, (unknown), (unknown), Jesper Eugen‐Olsen, Evangelos J. Giamarellos‐Bourboulis	8
3	Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation 2024 ·Critical Care Medicine ·(unknown), Isis Ricaño-Ponce, Nikolaos Antonakos, Evdoxia Kyriazopoulou, Antigone Kotsaki, Iraklis Tsangaris, Dimitra Markopoulou, Νikoletta Ρovina, Eleni Antoniadou, Ioannis Koutsodimitropoulos, George N. Dalekos, Glykeria Vlachogianni, Karolina Akinosoglou, Vasilios Koulouras, Apostolos Komnos, (unknown), George Dimοpoulos, Mihai G. Netea, Vinod Kumar, Evangelos J. Giamarellos‐Bourboulis	4
4	Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity 2023 ·Critical Care ·(unknown), Antigone Kotsaki, (unknown), Matthijs Kox, Peter Pickkers, Erik J. M. Toonen, Evangelos J. Giamarellos‐Bourboulis, Mihai G. Netea	14
5	Evaluation of the Novel Sepsis Biomarker Host-Derived Delta-like Canonical Notch Ligand 1—A Secondary Analysis of 405 Patients Suffering from Inflammatory or Infectious Diseases 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Konstantinos Leventogiannis, Antigone Kotsaki, Theodora Kanni, Nikolaos Antonakos, (unknown), Georgia Damoraki, Judith Schenz, Felix C. F. Schmitt, Florian Uhle, Markus A. Weigand, Evangelos J. Giamarellos‐Bourboulis, Maximilian Dietrich	2
6	ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol 2022 ·BMJ Open ·Antigone Kotsaki, Peter Pickkers, Michael Bauer, Thierry Calandra, Mihaela Lupșe, W. Joost Wiersinga, Sylvain Meylan, Frank Bloos, Tom van der Poll, Marleen A. Slim, Niels van Mourik, Marcella C.A. Müller, (unknown), Alexander P. J. Vlaar, Aline de Nooijer, (unknown), Sebastian Weis, Nikolaos Antonakos, Mihai G. Netea, Evangelos J. Giamarellos‐Bourboulis	31
7	Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled Phase 4 trial 2022 ·EClinicalMedicine ·Antigone Kotsaki, Nikolaos Tziolos, (unknown), Ioannis Koutelidakis, Styliani Symbardi, (unknown), (unknown), Zoi Alexiou, Helen Sambatakou, Konstantinos G. Toutouzas, Karolina Akinosoglou, Malvina Lada, Evangelos J. Giamarellos‐Bourboulis, Alasdair MacGowan	4
8	A 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among emergency department patients 2021 ·Intensive Care Medicine Experimental ·(unknown), James Wacker, (unknown), (unknown), (unknown), Antigone Kotsaki, Ioannis Koutelidakis, (unknown), (unknown), Oliver Liesenfeld, Timothy E. Sweeney, Evangelos J. Giamarellos‐Bourboulis	14
9	Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly 2020 ·Cell ·Evangelos J. Giamarellos‐Bourboulis, Μαρία Τσιλικά, Simone J.C.F.M. Moorlag, Nikolaos Antonakos, Antigone Kotsaki, Jorge Domínguez‐Andrés, Evdoxia Kyriazopoulou, Theologia Gkavogianni, Maria‐Evangelia Adami, Georgia Damoraki, Panagiotis Koufargyris, (unknown), (unknown), Hans J. P. M. Koenen, Reinout van Crevel, (unknown), Georgios Renieris, Antonios Papadopoulos, Mihai G. Netea	258
10	Validation of Inflammopathic, Adaptive, and Coagulopathic Sepsis Endotypes in Coronavirus Disease 2019 2020 ·Critical Care Medicine ·Timothy E. Sweeney, Oliver Liesenfeld, James Wacker, Yudong D. He, David Rawling, (unknown), (unknown), Uros Midic, Antigone Kotsaki, (unknown), Konstantinos Leventogiannis, (unknown), Evangelos J. Giamarellos‐Bourboulis	21
11	A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems 2018 ·European Journal of Clinical Microbiology & Infectious Diseases ·Evangelos J. Giamarellos‐Bourboulis, Antigone Kotsaki, Christina Routsi, Elena Graziano, Elda Righi, Matteo Bassetti	2
12	Angiopoietin-2 associations with the underlying infection and sepsis severity 2015 ·Cytokine ·(unknown), Dimitrios Velissaris, Antigone Kotsaki, Elli Antypa, (unknown), Θωμάς Τσαγανός, Despoina Koulenti, (unknown), Georgia Damoraki, (unknown), Stylianos E. Orfanos	30
13	Molecular diagnosis of sepsis 2012 ·Expert Opinion on Medical Diagnostics ·Antigone Kotsaki, Evangelos J. Giamarellos‐Bourboulis	6
14	Emerging drugs for the treatment of sepsis 2012 ·Expert Opinion on Emerging Drugs ·Antigone Kotsaki, Evangelos J. Giamarellos‐Bourboulis	31
15	Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa 2012 ·British Journal of Dermatology ·Athina Savva, Theodora Kanni, Georgia Damoraki, Antigone Kotsaki, S. Giatrakou, (unknown), Alexander Katoulis, Evangelia Papadavid, Evangelos J. Giamarellos‐Bourboulis	40
16	Early serum levels of soluble triggering receptor expressed on myeloid cells–1 in septic patients: Correlation with monocyte gene expression 2012 ·Journal of Critical Care ·Ioanna Dimopoulou, Αιμιλία Πελεκάνου, Irini Mavrou, Athina Savva, Marinella Tzanela, Antigone Kotsaki, Matina Kardara, Stylianos E. Orfanos, Αναστασία Κοτανίδου, Evangelos J. Giamarellos‐Bourboulis	27
17	Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection 2012 ·International Journal of Infectious Diseases ·Anastasia Antonopoulou, Fotini Baziaka, Θωμάς Τσαγανός, Maria Raftogiannis, Pantelis Koutoukas, Aikaterini Spyridaki, Maria Mouktaroudi, Antigone Kotsaki, Athina Savva, Marianna Georgitsi, Evangelos J. Giamarellos‐Bourboulis	34
18	Angiopoietin-2 Enhances Survival in Experimental Sepsis Induced by Multidrug-Resistant Pseudomonas aeruginosa 2012 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Evangelos J. Giamarellos‐Bourboulis, (unknown), Θωμάς Τσαγανός, Ralf A. Claus, Ilia Vaki, Αιμιλία Πελεκάνου, Antigone Kotsaki, (unknown), Stavros Topouzis, Michael Bauer, Andreas Papapetropoulos	18
19	Detrimental effect of apoptosis of lymphocytes at an early time point of experimental abdominal sepsis 2011 ·BMC Infectious Diseases ·Stefanos Atmatzidis, Ioannis Koutelidakis, Grigoris Chatzimavroudis, Antigone Kotsaki, (unknown), Aikaterini Pistiki, Athina Savva, Anastasia Antonopoulou, Konstantinos Atmatzidis, Evangelos J. Giamarellos‐Bourboulis	6
20	Eicosapentanoic acid prolongs survival and attenuates inflammatory response in an experimental model of lethal trauma 2010 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·(unknown), Θωμάς Τσαγανός, Evangelos J. Giamarellos‐Bourboulis, Antigone Kotsaki, Αpostolos Papalois, Nicolas Efstathopoulos	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact